Recommendations for prevention and control of hepatitis C virus (HCV) infection and HCV-related chronic disease. Centers for Disease Control and Prevention
- PMID:9790221
Recommendations for prevention and control of hepatitis C virus (HCV) infection and HCV-related chronic disease. Centers for Disease Control and Prevention
Abstract
These recommendations are an expansion of previous recommendations for the prevention of hepatitis C virus (HCV) infection that focused on screening and follow-up of blood, plasma, organ, tissue, and semen donors (CDC. Public Health Service inter-agency guidelines for screening donors of blood, plasma, organs, tissues, and semen for evidence of hepatitis B and hepatitis C. MMWR 1991;40[No. RR-41;1-17). The recommendations in this report provide broader guidelines for a) preventing transmission of HCV; b) identifying, counseling, and testing persons at risk for HCV infection; and c) providing appropriate medical evaluation and management of HCV-infected persons. Based on currently available knowledge, these recommendations were developed by CDC staff members after consultation with experts who met in Atlanta during July 15-17, 1998. This report is intended to serve as a resource for health-care professionals, public health officials, and organizations involved in the development, delivery, and evaluation of prevention and clinical services.
Similar articles
- Recommendations for the identification of chronic hepatitis C virus infection among persons born during 1945-1965.Smith BD, Morgan RL, Beckett GA, Falck-Ytter Y, Holtzman D, Teo CG, Jewett A, Baack B, Rein DB, Patel N, Alter M, Yartel A, Ward JW; Centers for Disease Control and Prevention.Smith BD, et al.MMWR Recomm Rep. 2012 Aug 17;61(RR-4):1-32.MMWR Recomm Rep. 2012.PMID:22895429
- Testing and Clinical Management of Health Care Personnel Potentially Exposed to Hepatitis C Virus - CDC Guidance, United States, 2020.Moorman AC, de Perio MA, Goldschmidt R, Chu C, Kuhar D, Henderson DK, Naggie S, Kamili S, Spradling PR, Gordon SC, Russi MB, Teshale EH.Moorman AC, et al.MMWR Recomm Rep. 2020 Jul 24;69(6):1-8. doi: 10.15585/mmwr.rr6906a1.MMWR Recomm Rep. 2020.PMID:32701942Free PMC article.
- CDC Recommendations for Hepatitis C Testing Among Perinatally Exposed Infants and Children - United States, 2023.Panagiotakopoulos L, Sandul AL; DHSc; Conners EE, Foster MA, Nelson NP, Wester C; Collaborators.Panagiotakopoulos L, et al.MMWR Recomm Rep. 2023 Nov 3;72(4):1-21. doi: 10.15585/mmwr.rr7204a1.MMWR Recomm Rep. 2023.PMID:37906518Free PMC article.
- NIH Consensus Statement on Management of Hepatitis C: 2002.[No authors listed][No authors listed]NIH Consens State Sci Statements. 2002 Jun 10-12;19(3):1-46.NIH Consens State Sci Statements. 2002.PMID:14768714Review.
- The hidden epidemic of hepatitis C virus infection in the United States: occult transmission and burden of disease.Ward JW.Ward JW.Top Antivir Med. 2013 Feb-Mar;21(1):15-9.Top Antivir Med. 2013.PMID:23596274Free PMC article.Review.
Cited by
- Trends in laboratory test volumes for Medicare Part B reimbursements, 2000-2010.Shahangian S, Alspach TD, Astles JR, Yesupriya A, Dettwyler WK.Shahangian S, et al.Arch Pathol Lab Med. 2014 Feb;138(2):189-203. doi: 10.5858/arpa.2013-0149-OA. Epub 2013 Jun 5.Arch Pathol Lab Med. 2014.PMID:23738761Free PMC article.
- Hepatitis C variability, patterns of resistance, and impact on therapy.Strahotin CS, Babich M.Strahotin CS, et al.Adv Virol. 2012;2012:267483. doi: 10.1155/2012/267483. Epub 2012 Jul 19.Adv Virol. 2012.PMID:22851970Free PMC article.
- Rapid diagnostic HCV antibody assays.Smith BD, Jewett A, Drobeniuc J, Kamili S.Smith BD, et al.Antivir Ther. 2012;17(7 Pt B):1409-13. doi: 10.3851/IMP2470. Epub 2012 Dec 7.Antivir Ther. 2012.PMID:23322678Free PMC article.Review.
- SASLT practice guidelines: management of hepatitis C virus infection.Alghamdi AS, Sanai FM, Ismail M, Alghamdi H, Alswat K, Alqutub A, Altraif I, Shah H, Alfaleh FZ; Saudi Association for the Study of Liver Diseases and Transplantation.Alghamdi AS, et al.Saudi J Gastroenterol. 2012 Sep;18 Suppl(Suppl 1):S1-32. doi: 10.4103/1319-3767.101155.Saudi J Gastroenterol. 2012.PMID:23006491Free PMC article.No abstract available.
- Improving Screening Methods for Hepatitis C Among People Who Inject Drugs: Findings from the HepTLC Initiative, 2012-2014.Blackburn NA, Patel RC, Zibbell JE.Blackburn NA, et al.Public Health Rep. 2016 May-Jun;131 Suppl 2(Suppl 2):91-7. doi: 10.1177/00333549161310S214.Public Health Rep. 2016.PMID:27168667Free PMC article.
Publication types
MeSH terms
Substances
Related information
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous